TARO - Taro Pharmaceutical Industries Ltd.
| Previous Close | 107.85 |
| Open | 107.62 |
| Bid | 107.85 x 100 |
| Ask | 108.79 x 100 |
| Day's Range | 107.21 - 109.20 |
| 52 Week Range | 92.28 - 124.52 |
| Volume | 17,801 |
| Avg. Volume | 98,972 |
| Market Cap | 4.39B |
| Beta | 0.14 |
| PE Ratio (TTM) | 11.05 |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Markit•5 hours agoSee what the IHS Markit Score report has to say about Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd NYSE:TARO
- Simply Wall St.•18 days ago
Does Taro Pharmaceutical Industries Ltd’s (TARO) PE Ratio Signal A Buying Opportunity?
Taro Pharmaceutical Industries Ltd (NYSE:TARO) is trading with a trailing P/E of 11.4x, which is lower than the industry average of 23.4x. While this makes TARO appear like a greatRead More...
Capital Cube•25 days agoTaro Pharmaceutical Industries Ltd. breached its 50 day moving average in a Bullish Manner : TARO-US : September 22, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Taro Pharmaceutical Industries Ltd.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)
- Capital Cube•last month
ETFs with exposure to Taro Pharmaceutical Industries Ltd. : September 14, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Taro Pharmaceutical Industries Ltd. Here are 5 ETFs with the largest exposure to TARO-US. Comparing the performance and risk of Taro Pharmaceutical Industries Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
Capital Cube•last monthTaro Pharmaceutical Industries Ltd. :TARO-US: Earnings Analysis: Q1, 2018 By the Numbers : September 13, 2017
Categories: Yahoo FinanceGet free summary analysis Taro Pharmaceutical Industries Ltd. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Taro Pharmaceutical Industries Ltd. – Mylan N.V., Valeant Pharmaceuticals International Inc, Merck & Co., Inc., Pfizer Inc., Johnson & Johnson, Teva Pharmaceutical Industries Limited Sponsored ADR, GlaxoSmithKline ... Read more (Read more...)
Markit•last monthSee what the IHS Markit Score report has to say about Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries Ltd NYSE:TARO
Markit•last monthSee what the IHS Markit Score report has to say about Taro Pharmaceutical Industries Ltd.
Short interest is low for TARO with fewer than 5% of shares on loan. The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices.
Capital Cube•2 months agoTaro Pharmaceutical Industries Ltd. – Value Analysis (NYSE:TARO) : August 21, 2017
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Taro Pharmaceutical Industries Ltd. a score of 75. Our analysis is based on comparing Taro Pharmaceutical Industries Ltd. with the following peers – Mylan N.V., Valeant Pharmaceuticals International Inc, Merck & Co., Inc., Pfizer Inc., Johnson & Johnson, Teva Pharmaceutical Industries Limited Sponsored ADR, GlaxoSmithKline plc Sponsored ... Read more (Read more...)
Markit•2 months agoSee what the IHS Markit Score report has to say about Taro Pharmaceutical Industries Ltd.
Short interest is low for TARO with fewer than 5% of shares on loan. The net inflows of $1.04 billion over the last one-month into ETFs that hold TARO are among the lowest of the last year and appear to be slowing.
Markit•2 months agoSee what the IHS Markit Score report has to say about Taro Pharmaceutical Industries Ltd.
Short interest is low for TARO with fewer than 5% of shares on loan. Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on August 10. The net inflows of $1.59 billion over the last one-month into ETFs that hold TARO are not among the highest of the last year and have been slowing.
Markit•2 months agoIHS Markit Score upgrades Taro Pharmaceutical Industries Ltd to 71 out of 100, despite ranking positively in only one IHS Markit category.
Short interest is low for TARO with fewer than 5% of shares on loan. The net inflows of $1.28 billion over the last one-month into ETFs that hold TARO are not among the highest of the last year and have been slowing.
- Associated Press•2 months ago
Taro posts 1Q profit
On a per-share basis, the Haifa Bay, Israel-based company said it had net income of $1.35. The drug maker posted revenue of $161.3 million in the period. Taro shares have increased nearly 4 percent since ...
Capital Cube•2 months agoTaro Pharmaceutical Industries Ltd. breached its 50 day moving average in a Bearish Manner : TARO-US : August 9, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Taro Pharmaceutical Industries Ltd.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)
- Capital Cube•3 months ago
ETFs with exposure to Taro Pharmaceutical Industries Ltd. : July 12, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Taro Pharmaceutical Industries Ltd. Here are 5 ETFs with the largest exposure to TARO-US. Comparing the performance and risk of Taro Pharmaceutical Industries Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
- Capital Cube•4 months ago
ETFs with exposure to Taro Pharmaceutical Industries Ltd. : June 27, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Taro Pharmaceutical Industries Ltd. Here are 5 ETFs with the largest exposure to TARO-US. Comparing the performance and risk of Taro Pharmaceutical Industries Ltd. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)
Capital Cube•4 months agoTaro Pharmaceutical Industries Ltd. :TARO-US: Earnings Analysis: Q4, 2017 By the Numbers : June 26, 2017
Categories: Yahoo FinanceGet free summary analysis Taro Pharmaceutical Industries Ltd. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Taro Pharmaceutical Industries Ltd. – Mylan N.V., Pfizer Inc., Merck & Co., Inc., Valeant Pharmaceuticals International Inc, Teva Pharmaceutical Industries Limited Sponsored ADR, GlaxoSmithKline plc Sponsored ADR, ... Read more (Read more...)
- Capital Cube•4 months ago
Taro Pharmaceutical Industries Ltd. breached its 50 day moving average in a Bullish Manner : TARO-US : June 21, 2017
Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Taro Pharmaceutical Industries Ltd.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)
- Thomson Reuters StreetEvents•5 months ago
Edited Transcript of TARO earnings conference call or presentation 23-May-17 12:00pm GMT
Q4 2017 Taro Pharmaceutical Industries Ltd Earnings Call
- TheStreet.com•5 months ago
Perrigo, Taro Show Perils of Failure to Branch in Branded Drugs
The latest earnings from two of the largest generic drug makers show how important it is for generic firms to have their own stable of higher-margin branded products.
- Associated Press•5 months ago
Taro posts 4Q profit
On a per-share basis, the Haifa Bay, Israel-based company said it had profit of $2.05. The drug maker posted revenue of $196.4 million in the period. For the year, the company reported profit of $456.4 ...
Capital Cube•5 months agoTaro Pharmaceutical Industries Ltd. breached its 50 day moving average in a Bearish Manner : TARO-US : May 15, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Taro Pharmaceutical Industries Ltd.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day ... Read more (Read more...)
Capital Cube•5 months agoTaro Pharmaceutical Industries Ltd. breached its 50 day moving average in a Bearish Manner : TARO-US : May 4, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Taro Pharmaceutical Industries Ltd.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day ... Read more (Read more...)
- Capital Cube•6 months ago
Taro Pharmaceutical Industries Ltd. – Value Analysis (NYSE:TARO) : April 25, 2017
Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Taro Pharmaceutical Industries Ltd. a score of 84. Our analysis is based on comparing Taro Pharmaceutical Industries Ltd. with the following peers – Mylan N.V., Pfizer Inc., Merck & Co., Inc., Valeant Pharmaceuticals International Inc, Johnson & Johnson, Teva Pharmaceutical Industries Limited Sponsored ADR, GlaxoSmithKline plc Sponsored ... Read more (Read more...)
Capital Cube•6 months agoTaro Pharmaceutical Industries Ltd. breached its 50 day moving average in a Bearish Manner : TARO-US : April 24, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Taro Pharmaceutical Industries Ltd.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day ... Read more (Read more...)
